0001415889-18-000910.txt : 20180608
0001415889-18-000910.hdr.sgml : 20180608
20180608170532
ACCESSION NUMBER: 0001415889-18-000910
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180606
FILED AS OF DATE: 20180608
DATE AS OF CHANGE: 20180608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brege Laura
CENTRAL INDEX KEY: 0001365619
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 18890241
MAIL ADDRESS:
STREET 1: C/O ONYX PHARMACEUTICALS, INC.
STREET 2: 2100 POWELL STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
form4-06082018_020616.xml
X0306
4
2018-06-06
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001365619
Brege Laura
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
true
false
false
false
Stock option (right to buy)
17.52
2018-06-06
4
A
0
15000
0
A
2028-06-05
Common Stock
15000
15000
D
25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant.
/s/ Glenn F. Baity, Attorney-in-Fact
2018-06-08